| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K03536150 |
| PharmacoGx | BRD-K03536150 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ACSM4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | ST14 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | OPRD1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | C20orf96 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | LTF | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | GOLGA8H | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | TCEA1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | PBRM1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | TRIM69 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ZNF510 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
